The ERMAP gene helps make a surface protein found mainly on developing red blood cells. If this gene does not work as expected, the markers on red blood cells can differ, which may matter for blood typing and transfusions, and rare more disruptive variants can cause a condition affecting growth, skin, and other parts of the body. Many people first learn about the ERMAP gene through blood bank testing because it is linked to the Scianna blood group system.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Some genes provide the code for proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain activities happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, more information is available in the LearnHub.
Overview
ERMAPGene function
What if the gene works
Your red blood cells use the ERMAP gene to make a surface protein that carries the Scianna blood group markers. This protein may help developing red blood cells interact and mature normally.
Risk
What if the gene does not work
Depending on the variant, ERMAP may slightly alter or completely remove the Scianna protein from red blood cells. This changes which Scianna markers appear on the cell surface and how those cells are recognized by antibodies.
Treatment
What does that mean for your treatment
No drug treatment is tailored to pathogenic variants in the ERMAP gene. Treatment relevance is mainly in transfusion care: if you have antibodies to Scianna blood group antigens linked to ERMAP, clinicians can choose blood that lacks the relevant antigen to reduce the chance of a transfusion reaction.
Gene function
What if the gene works
ERMAP helps shape the outer surface of developing red blood cells and mature red blood cells. Its protein sits in the cell membrane, where it contributes to how these cells are recognized by other cells and by the immune system. This background helps explain normal blood group features and routine red blood cell development.
The ERMAP gene makes a red blood cell surface protein that becomes part of the cell membrane. This helps developing and mature red blood cells present stable features on their outer surface.
The ERMAP protein carries the Scianna blood group antigens on red blood cells. These are normal inherited surface markers that help give each person’s red blood cells their own surface identity.
ERMAP belongs to a protein family often used when cells recognize one another and make contact at the surface. In red blood cell development, this design supports routine interactions between neighboring cells.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ERMAP gene can alter the ERMAP protein’s shape, stability, or delivery to the red blood cell surface. In practical terms, how ERMAP gene variants affect protein function depends on the type of DNA change: some missense variants subtly change the protein and reduce antigen display, while more disruptive variants can impair folding, disrupt splicing, or stop the protein from reaching the cell membrane. This creates a spectrum from milder functional changes to near-complete loss of surface expression.
How variants are linked to conditions
Variants in the ERMAP gene are best known for defining the Scianna blood group system. In discussions of ERMAP gene variants linked to conditions, the main clinical issue is blood type incompatibility: during pregnancy or a transfusion, a mismatch may be associated with hemolytic disease of the fetus and newborn or hemolytic transfusion reactions. Most people carrying an ERMAP variant are healthy unless this kind of immune mismatch occurs.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and occur commonly across the population. Most do not directly affect health and instead represent normal human variation. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. There are cases, though, where one well-characterized variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ERMAP gene. In practice, risk depends mainly on the exact gene change and whether it affects blood group matching, especially during transfusion or pregnancy. Anyone concerned about their personal risk should speak with a doctor or genetic counselor.
Inheritance of ERMAP variants
There is not yet a broadly confirmed disease specific inheritance pattern for the ERMAP gene, so the answer to how ERMAP variants are inherited is still evolving. ERMAP is located on chromosome 1, which is an autosome, so you inherit one copy from each parent. In practice, this means an ERMAP gene change can be passed down through either side of the family, rather than following an X linked or mitochondrial pattern.
What does my ERMAP result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for ERMAP, though this can change as research develops. If you have a specific ERMAP result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your relatives and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ERMAP variants usually uses a blood or saliva sample. A lab reads the ERMAP gene, often as part of blood group genotyping or a broader DNA panel, to look for changes that can show whether you carry a variant and help explain unusual blood typing results.
When should I consider getting a genetic test?
Testing the ERMAP gene may be worth considering if blood bank results suggest a rare blood type linked to this gene, especially after a transfusion reaction or during pregnancy. It can help explain unexpected blood antibodies and guide safer blood matching.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is best viewed together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it into tissues, or responds to it at its target. This helps explain why the same medication works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes can shape a person’s response to medicines. It examines links between genes and medications to help explain why the same treatment may not work the same way for everyone. With many drugs, genes can influence either how powerfully a medicine works or how the body handles it. This information can support treatment choices that are both better informed and more personalized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ERMAP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about side effects, new symptoms after starting treatment, or whether a medication is safe to use are best discussed with your doctor.
History
ERMAP entered medical genetics through blood group research rather than public headlines. The story began in the 1960s, when the Scianna blood group system was recognized after unusual red blood cell reactions were seen in a family. Initially understood only through visible blood typing patterns, it was later linked to a specific gene on chromosome 1. From these first observations, research expanded steadily, and scientists identified the ERMAP gene as the source of Scianna blood group antigens on red blood cells. This helped explain why some people develop antibodies to these blood group markers during transfusion testing or pregnancy care. Over time, descriptions became more precise as DNA-based testing confirmed the gene behind the long-known blood group pattern.